Your browser doesn't support javascript.
loading
Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial.
Chiang, Chi Leung; Chiu, Keith Wan Hang; Chan, Kenneth Sik Kwan; Lee, Francis Ann Shing; Li, James Chun Bong; Wan, Catherine Wing Suet; Dai, Wing Chiu; Lam, Tai Chung; Chen, Wenqi; Wong, Natalie Sean Man; Cheung, Andy Lai Yin; Lee, Venus Wan Yan; Lau, Vince Wing Hang; El Helali, Aya; Man, Kwan; Kong, Feng Ming Spring; Lo, Chung Mau; Chan, Albert Chi-Yan.
Afiliação
  • Chiang CL; Department of Clinical Oncology, Queen Mary Hospital, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China; Clinical Oncology Center, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Chiu KWH; Department of Diagnostic Radiology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • Chan KSK; Department of Clinical Oncology, Queen Mary Hospital, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • Lee FAS; Department of Clinical Oncology, Tuen Mun Hospital, Tuen Mun, Hong Kong Special Administrative Region, China.
  • Li JCB; Department of Pediatrics and Adolescent Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • Wan CWS; Department of Diagnostic Radiology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • Dai WC; Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • Lam TC; Department of Clinical Oncology, Queen Mary Hospital, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China; Clinical Oncology Center, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Chen W; Clinical Oncology Center, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Wong NSM; Department of Clinical Oncology, Tuen Mun Hospital, Tuen Mun, Hong Kong Special Administrative Region, China.
  • Cheung ALY; Medical Physics Unit, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • Lee VWY; Medical Physics Unit, Tuen Mun Hospital, Tuen Mun, Hong Kong Special Administrative Region, China.
  • Lau VWH; Department of Diagnostic Radiology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China; Department of Radiology, Gleneagles Hospital, Hong Kong Special Administrative Region, China.
  • El Helali A; Department of Clinical Oncology, Queen Mary Hospital, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • Man K; Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • Kong FMS; Department of Clinical Oncology, Queen Mary Hospital, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China; Clinical Oncology Center, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
  • Lo CM; Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.
  • Chan AC; Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China. Electronic address: acchan@hku.hk.
Lancet Gastroenterol Hepatol ; 8(2): 169-178, 2023 02.
Article em En | MEDLINE | ID: mdl-36529152
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radiocirurgia / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radiocirurgia / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article